private:globalcellsolutions
|
3163164
|
May 25th, 2019 12:00AM
|
Global Cell Solutions Inc.
|
78
|
3.00
|
Open
|
Biotechnology
|
May 25th, 2019 08:47AM
|
May 25th, 2019 08:47AM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
Open
|
|
Open
|
770 Harris Street Ste 104
|
Charlottesville
|
VA
|
US
|
22903
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 17th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 16th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 15th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 14th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 13th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 12th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 11th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 10th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:globalcellsolutions
|
3163164
|
Feb 9th, 2018 12:00AM
|
Global Cell Solutions Inc.
|
64
|
6.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Global Cell Solutions, Inc. provides three-dimensional cell culturing tools and cell-based assays to researchers engaged in the fields of biotechnology, drug discovery, and pharmaceutical research.
Headquartered in Charlottesville, Virginia, GCS is focused on the application of a novel and dramatically improved patent-pending cell culturing technique. GCS is positioned to be an integral partner to the next generation of scientific breakthroughs in medicine, research, biotechnology, pharmaceuticals and the emerging field of orthobiologics.
Partnering with the Medical Automation Research Center at the University of Virginia’s School of Medicine, GCS was awarded a STTR Phase I grant from the National Cancer Institute at the National Institutes of Health. This grant supports the R&D efforts for the development and production of our microcarriers and automation platforms for various cell culture applications.
Global Cell technology is already establishing itself as an indispensable tool for improving research efficiency through higher cell quality and production by employing the latest in three-dimensional biology paradigms.
|
|
|
|
|
|
|
|
|
|
Global Cell Solutions
|
Health Care
|
Pharmaceuticals & Biotechnology
|